Oscar Health Inc. Class A Common Stock (OSCR)
Stock · NYSE · Health Care
$31.89as of 10/16/2026
Price chart
Active signals
OSCR Signal Track Record
How signals performed across all stocks →What OSCR's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | +1.8% | 54% | September 11, 2026 |
| Bollinger Band Breakout | 26 | +4.6% | 58% | September 14, 2026 |
| Bollinger Band Breakdown | 19 | +9.5% | 63% | August 6, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -2.4% | 44% | April 17, 2026 |
| Any 20-session window (baseline) | +2.8% | 54% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About OSCR
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers bro…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 2,305
- Website
- www.hioscar.com/
Fundamentals
- 1-day range
- $32.05$33.43
- Market cap
- $8.00B
- P/E (trailing)
- 18.32
- P/E (forward)
- 14.55
- EPS (trailing)
- $1.37
- Dividend yield
- —
- Beta
- 2.51
- Avg. volume
- 5.28M
How Oscar Health Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 13, 2026 · via SEC EDGAR / Finnhub
Forecasts
10 analyst ratings
Oscar Health Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- OSCROscar Health Inc. Class A Common Stock$31.89▼ 4.72%Market cap $8.00BP/E 18.32$10.69$35.01
- MOHMolina Healthcare Inc Common Stock$207.36▼ 2.42%Market cap $10.02BP/E 1257.31$121.06$244.89
- CAICaris Life Sciences Inc. Common Stock$30.56▼ 3.78%Market cap $5.65BP/E 76.07$14.19$33.66
- RDNTRadNet Inc. Common Stock$68.8▼ 2.29%Market cap $5.36BP/E —$50.82$85.84
- CELCCelcuity Inc. Common Stock$56.58▼ 6.17%Market cap $4.55BP/E —$46.51$151.02
- BLLNBillionToOne Inc. Class A Common Stock$98.12▼ 4.49%Market cap $4.22BP/E 128.54$61.96$150.44
- CONConcentra Group Holdings Parent Inc. Common Stock$38.54▼ 1.56%Market cap $3.91BP/E 24.09$18.55$38.07
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OSCR Oscar Health Inc. Class A Common Stock | $8.00B | 18.32 | $31.89 | ▼ 4.72% | $10.69$35.01 |
| MOH Molina Healthcare Inc Common Stock | $10.02B | 1257.31 | $207.36 | ▼ 2.42% | $121.06$244.89 |
| CAI Caris Life Sciences Inc. Common Stock | $5.65B | 76.07 | $30.56 | ▼ 3.78% | $14.19$33.66 |
| RDNT RadNet Inc. Common Stock | $5.36B | — | $68.8 | ▼ 2.29% | $50.82$85.84 |
| CELC Celcuity Inc. Common Stock | $4.55B | — | $56.58 | ▼ 6.17% | $46.51$151.02 |
| BLLN BillionToOne Inc. Class A Common Stock | $4.22B | 128.54 | $98.12 | ▼ 4.49% | $61.96$150.44 |
| CON Concentra Group Holdings Parent Inc. Common Stock | $3.91B | 24.09 | $38.54 | ▼ 1.56% | $18.55$38.07 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- UBS Maintains Neutral on Oscar Health, Raises Price Target to $36benzinga · 10/12/2026
- 2 Growth Stocks with Explosive Upside and 1 We AvoidYahoo · 10/9/2026
- Best Growth Stocks to Buy for October 9thYahoo · 10/9/2026
- Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To ShareholdersBenzinga · 10/9/2026
- Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?Yahoo · 10/8/2026
- Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for InvestorsYahoo · 10/7/2026
- Why Oscar Health (OSCR) Is Up 8.6% After Raising 2026 Outlook On AI-Driven Q2 BeatYahoo · 10/7/2026
- Zacks Industry Outlook Prudential Financial, Assurant, Oscar and Horace MannYahoo · 10/7/2026
- Best Growth Stocks to Buy for October 7thYahoo · 10/7/2026
Insider Activity
Insider Actions →- Kushner Joshua · September 18, 2026 · J75.5K
- Kushner Joshua · September 18, 2026 · J6.27M
- Kushner Joshua · September 18, 2026 · J164.2K
- Kushner Joshua · September 18, 2026 · J4.86M
- Kushner Joshua · September 18, 2026 · J1.32M
- Thrive Partners II GP, LLC · September 18, 2026 · J75.5K
- Thrive Partners II GP, LLC · September 18, 2026 · J6.27M
- Thrive Partners II GP, LLC · September 18, 2026 · J164.2K
- Thrive Partners II GP, LLC · September 18, 2026 · J4.86M
- Thrive Partners II GP, LLC · September 18, 2026 · J1.32M
- Vanessa Ames Wittman · September 18, 2026 · Sale25.0K @ $32.24
- Adam McAnaney · September 3, 2026 · Sale9.1K @ $31.45
- Janet Liang · September 3, 2026 · Sale10.4K @ $31.45
- Richard Scott Blackley · September 3, 2026 · Sale28.9K @ $31.45
- Victoria Baltrus · September 3, 2026 · Sale958 @ $31.45
Institutional Ownership
March 31, 2026
- Total shares held
- 184.01M
- Total value held
- $1.94B
- Institutional holders
- 325
- Unknown17.31M
- Unknown11.64M
- Unknown10.78M
- Unknown9.65M
- Unknown7.79M
- Unknown7.03M
- Unknown6.57M
- Unknown6.43M
- Unknown6.34M
- Unknown6.32M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Oscar Health Analyst Target Rises to $34.19
Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.
Oscar Health Analyst Target Rises to $34.19. Analysts raised the consensus price target for Oscar Health by 12.09% to $34.19. This adjustment follows recent updates to the company's earnings roadmap and new product initiatives. The stock is currently trading near the upper end of its 52-week range, reflecting renewed interest in its growth prospects.